The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1989-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.86.22.8857PMID 2682662PMCID PMC298389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a 130 Kda bcr related gene product.

  1989cited by this paper
• Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

  1989cited by this paper
• Identification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activity

  1988cited by this paper
• Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

  1988cited by this paper
• The molecular genetics of cancer.

  1987cited by this paper
• Oncogenes in development.

  1987cited by this paper
• Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences

  1987cited by this paper
• The cDNA sequence and gene analysis of the human pim oncogene.

  1987cited by this paper
• Comparison of the human and mouse PIM-1 cDNAs: nucleotide sequence and immunological identification of the in vitro synthesized PIM-1 protein.

  1987cited by this paper
• Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations

  1987cited by this paper
• Characterization of the human PIM-1 gene: a putative proto-oncogene coding for a tissue specific member of the protein kinase family.

  1987cited by this paper
• Fragile sites are targets of diverse mutagens and carcinogens.

  1987cited by this paper
• Immunologic classification of leukemia and lymphoma.

  1986cited by this paper
• c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages.

  1986cited by this paper
• The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases.

  1986cited by this paper
• Expression of cellular oncogenes in primary cells from human acute leukemias.

  1986cited by this paper
• Localization of the human pim oncogene (PIM) to a region of chromosome 6 involved in translocations in acute leukemias.

  1986cited by this paper
• Enhanced expression of the N-myc gene in Wilms' tumors.

  1986cited by this paper
• Isoenzyme studies in human leukemia-lymphoma cell lines--1. Carboxylic esterase.

  1985cited by this paper
• Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.

  1985cited by this paper
• Cell-type-specific pattern of myc protooncogene expression in developing human embryos.

  1985cited by this paper
• Proviral activation of the putative oncogene Pim‐1 in MuLV induced T‐cell lymphomas.

  1985cited by this paper
• Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies

  1984cited by this paper
• Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

  1984cited by this paper
• Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas.

  1984cited by this paper
• B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

  1984cited by this paper
• Activation of the cellular oncogene c-erbB by LTR insertion: molecular basis for induction of erythroblastosis by avian leukosis virus.

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Differential expression of cellular oncogenes during pre- and postnatal development of the mouse

  1982cited by this paper
• Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis

  1981cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper

• Synergistic apoptosis induction in myelodysplastic syndrome cells by azacitidine and PIM-2 inhibitors via nuclear factor-kappa B pathway inhibition

  2026cites this paper
• Exploring the Potential of Baicalin and Resveratrol as PIM-1 Kinase Inhibitors: Therapeutic Targeting of Prostate and Breast Cancers

  2024cites this paper
• Pim1 is critical in T-cell-independent B-cell response and MAPK activation in B cells.

  2024cites this paper
• PIM1 kinase and its diverse substrate in solid tumors

  2024cites this paper
• Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation

  2023cites this paper
• An overview of pim kinase as a target in multiple myeloma

  2023cites this paper
• Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia

  2023cites this paper
• Targeting Pim kinases in hematological cancers: molecular and clinical review

  2023cites this paper
• Linking Benzene, in Utero Carcinogenicity and Fetal Hematopoietic Stem Cell Niches: A Mechanistic Review

  2023cites this paper
• Anticancer therapeutic potential of benzofuran scaffolds

  2023cites this paper
• Potassium 6-Oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate

  2023cites this paper
• Combining machine learning and structure-based approaches to develop oncogene PIM kinase inhibitors

  2023cites this paper
• The Role of PIM Kinases in Pediatric Solid Tumors

  2022cites this paper
• PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer

  2022cites this paper
• In silico design of novel anticancer drugs with amino acid and carbohydrate building blocks to inhibit PIM kinases

  2022cites this paper
• Pre-T cell receptor self-MHC sampling restricts thymocyte dedifferentiation

  2022cites this paper
• Pathway-Directed Therapy in Multiple Myeloma

  2021cites this paper
• Design of new 3, 5-disubstituted indole as hematological anticancer agents using 3D-QSAR, molecular docking and drug-likeness studies

  2021cites this paper
• Mitochondrial metabolism and carcinogenesis

  2021cites this paper
• New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation

  2021cites this paper
• Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase

  2021cites this paper
• OTT_A_245578 6897..6905

  2020cites this paper
• The role of Pim kinase in immunomodulation.

  2020cites this paper
• Bisindolemethane derivatives as highly potent anticancer agents: Synthesis, medicinal activity evaluation, cell-based compound discovery, and computational target predictions

  2020cites this paper
• High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms

  2020cites this paper
• Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family.

  2020cites this paper
• Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia

  2020cites this paper
• Expression of Proviral Integration of Moloney Virus-2 (PIM2) Gene in Patients with Acute Myeloid Leukemia and its Clinical Significance

  2020cites this paper
• Discovery of SARxxxx92, a pan-PIM kinase Inhibitor, efficacious in a KG1 tumor model.

  2020cites this paper
• PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells

  2020cites this paper
• Differential expression pattern of genes involved in oxygen metabolism in epithelial oviductal cells during primary in vitro culture

  2019cites this paper
• Paternal Smoking Before Conception and During Pregnancy Is Associated With an Increased Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis of 17 Case-Control Studies

  2019cites this paper
• A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs.

  2019cites this paper
• Targeting the immunity protein kinases for immuno-oncology.

  2019cites this paper
• Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer.

  2019cites this paper
• Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.

  2019cites this paper
• Understanding PIM-1 kinase inhibitor interactions with free energy simulation.

  2019cites this paper
• New mechanistic insight on the PIM-1 kinase inhibitor AZD1208 using multidrug resistant human erythroleukemia cell lines and molecular docking simulations.

  2019cites this paper
• FLT3 inhibitor quizartinib (AC220)

  2019cites this paper
• Modeling drug-drug interactions of AZD1208 with Vincristine and Daunorubicin on ligand-extrusion binding TMD-domains of multidrug resistance P-glycoprotein (ABCB1).

  2019cites this paper
• Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies

  2019cites this paper
• Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors - Lead optimization - Part III.

  2019cites this paper
• Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study

  2018cites this paper
• Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors.

  2018cites this paper
• Downregulation of Pim-2 induces cell cycle arrest in the G0/G1 phase via the p53-non-dependent p21 signaling pathway

  2018cites this paper
• Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

  2018cites this paper
• PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression

  2018cites this paper
• High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement

  2018cites this paper
• PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes

  2018cites this paper
• Expression and significance of Pim‐3 kinase in adult T‐cell leukemia

  2017cites this paper
• Rational Design of a Potent Pan-Pim Kinases Inhibitor with a Rhodanine-Benzoimidazole Structure.

  2017cites this paper
• Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II.

  2017cites this paper
• Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus

  2017cites this paper
• Spectrum of T‐lymphocyte activities regulating allergic lung inflammation

  2017cites this paper
• Cell-Specific Computational Modeling of the PIM Pathway in Acute Myeloid Leukemia.

  2017cites this paper
• Discovery of N-substituted 7-azaindoles as PIM1 kinase inhibitors - Part I.

  2017cites this paper
• University of Dundee A functional SUMO-motif in the active site of PIM 1 promotes its degradation via RNF 4 , and stimulates protein kinase activity

  2017cites this paper
• The role of Pim-1 in breast cancer metastasis

  2017cites this paper
• Theoretical Analysis of Activity Cliffs among Benzofuranone-Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach

  2017cites this paper
• A functional SUMO-motif in the active site of PIM1 promotes its degradation via RNF4, and stimulates protein kinase activity

  2017cites this paper
• Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.

  2016cites this paper
• Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells

  2016cites this paper
• Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer

  2016cites this paper
• Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia

  2016cites this paper
• Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).

  2016cites this paper
• The role of PIM 1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma

  2016cites this paper
• The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.

  2016cites this paper
• Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease

  2016cites this paper
• Binding site identification and role of permanent water molecule of PIM-3 kinase: A molecular dynamics study.

  2015cites this paper
• Bioactive Benzofuran derivatives: A review.

  2015cites this paper
• Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 Inhibitors.

  2015cites this paper
• Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells.

  2015cites this paper
• MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.

  2015cites this paper
• Design, synthesis and biological evaluation of novel C3-functionalized oxindoles as potential Pim-1 kinase inhibitors

  2015cites this paper
• Correlation between the Stereochemistry and Bioactivity in Octahedral Rhodium Prolinato Complexes.

  2015cites this paper
• PIM Kinases in AML

  2015cites this paper
• Bioactive benzofuran derivatives: An insight on lead developments, radioligands and advances of the last decade.

  2015cites this paper
• Targeted therapy of acute myeloid leukemia

  2015cites this paper
• Structure-based design of low-nanomolar PIM kinase inhibitors.

  2015cites this paper
• Mechanism-based combinations with Pim kinase inhibitors in cancer treatments.

  2014cites this paper
• More than just a GPCR ligand: structure-based discovery of thioridazine derivatives as Pim-1 kinase inhibitors

  2014cites this paper
• The application of a 3D-QSAR Approach for 7-(4H-1,2,4-Triazol-3-yl) benzo(c) (2,6) naphthyridine Derivatives as PIM - 1 Inhibitors

  2014cites this paper
• MYELOID NEOPLASIA AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates ef fi cacy in preclinical models of acute myeloid leukemia

  2014cites this paper
• Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications.

  2014cites this paper
• EBNA3C Augments Pim-1 Mediated Phosphorylation and Degradation of p21 to Promote B-Cell Proliferation

  2014cites this paper
• Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer

  2014cites this paper
• PIM kinases: an overview in tumors and recent advances in pancreatic cancer.

  2014cites this paper
• AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.

  2014cites this paper
• hematopoietic cells The transcriptome of the leukemogenic homeoprotein HOXA9 in human

  2013cites this paper
• RNAi-based anti-cancer strategies - targeting the proto-oncogene PIM1 and oncogenic miRNAs

  2013cites this paper
• The role of quizartinib in the treatment of acute myeloid leukemia

  2013cites this paper
• Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells

  2013cites this paper
• The PIM-2 Kinase Is an Essential Component of the Ultraviolet Damage Response That Acts Upstream to E2F-1 and ATM*

  2013cites this paper
• Targeting aberrant kinase activity in myeloid leukaemias

  2013cites this paper
• A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling.

  2013cites this paper
• Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.

  2013cites this paper
• Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients

  2013cites this paper
• Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice

  2013cites this paper
• Photo-physics study of an hydroxy-quinoline derivative as inhibitor of Pim-1 kinase: ultraviolet-visible linear dichroism spectroscopy and quantum chemical calculations.

  2013cites this paper
• Tricyclic Benzo[cd]azulenes Selectively Inhibit Activities of Pim Kinases and Restrict Growth of Epstein-Barr Virus-Transformed Cells

  2013cites this paper